EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced Chemo‐Immunotherapy Strategy Utilizing Injectable Thermosensitive Hydrogel for The Treatment of Diffuse Peritoneal Metastasis in Advanced Colorectal Cancer

Meng Wang, DanRong Hu, Yun Yang, Kun Shi, JiaNan Li, QingYa Liu, YiCong Li, Ran Li, Meng Pan, Dong Mo, Wen Chen, XiCheng Li und 1 weitere

Advanced Science · 2023

DOI: 10.1002/advs.202303819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Meng Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Colorectal Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, West China Hospital, Sichuan University, Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with colorectal cancer (CRC) and diffuse peritoneal metastasis (PM) are not eligible for surgical intervention. Thus, palliative treatment remains the standard of care in clinical practice. Systemic chemotherapy fails to cause drug accumulation at the lesion sites, while intraperitoneal chemotherapy (IPC) is limited by high clearance rates and associated complications. Given the poor prognosis, a customized OxP/R848@PLEL hydrogel delivery system has been devised to improve the clinical benefit of advanced CRC with diffuse PM. This system is distinguished by its simplicity, security, and efficiency. Specifically, the PLEL hydrogel exhibits excellent injectability and thermosensitivity, enabling the formation of drug depots within the abdominal cavity, rendering it an optimal carrier for IPC. Oxaliplatin (OxP), a first‐line drug for advanced CRC, is cytotoxic and enhances the immunogenicity of tumors by inducing immunogenic cell death. Furthermore, OxP and resiquimod (R848) synergistically enhance the maturation of dendritic cells, promote the expansion of cytotoxic T lymphocytes, and induce the formation of central memory T cells. Moreover, R848 domesticates macrophages to an anti‐tumor phenotype. OxP/R848@PLEL effectively eradicates peritoneal metastases, completely inhibits ascites production, and significantly prolongs mice lifespan. As such, it provides a promising approach to managing diffuse PM in patients with CRC without surgical indications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsColorectal NeoplasmsAntineoplastic AgentsHumansAnimalsMiceHydrogelsOxaliplatinImmunotherapy

Stichwörter der Autor:innen

chemo-immunotherapycolorectal cancerdiffuse peritoneal metastasisintraperitoneal chemotherapythermosensitive hydrogel

Substanzen

HydrogelsAntineoplastic AgentsOxaliplatin

Autor:innen und Institutionen

  • Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Rehabilitation Medicine Center and Institute of Rehabilitation Medicine, Key Laboratory of Rehabilitation Medicine in Sichuan Province, West China Hospital, Sichuan University, Chengdu, 610041, China.

ORCID-Profile: ZhiYong Qian

Förderung

  • National Natural Science Foundation of China
  • West China Hospital, Sichuan University
  • Natural Science Foundation of Sichuan Province
  • Sichuan Science and Technology Program, China

Zitieren

APA

Wang, M., Hu, D., Yang, Y., Shi, K., Li, J., Liu, Q., Li, Y., Li, R., Pan, M., Mo, D., Chen, W., Li, X., & Qian, Z. (2023). Enhanced Chemo‐Immunotherapy Strategy Utilizing Injectable Thermosensitive Hydrogel for The Treatment of Diffuse Peritoneal Metastasis in Advanced Colorectal Cancer. Advanced Science. https://doi.org/10.1002/advs.202303819

Vancouver

Wang M, Hu D, Yang Y, Shi K, Li J, Liu Q, et al. Enhanced Chemo‐Immunotherapy Strategy Utilizing Injectable Thermosensitive Hydrogel for The Treatment of Diffuse Peritoneal Metastasis in Advanced Colorectal Cancer. Advanced Science. 2023. doi:10.1002/advs.202303819

BibTeX
@article{Wang2023,
  author = {Wang, Meng and Hu, DanRong and Yang, Yun and Shi, Kun and Li, JiaNan and Liu, QingYa and Li, YiCong and Li, Ran and Pan, Meng and Mo, Dong and Chen, Wen and Li, XiCheng and Qian, ZhiYong},
  title = {Enhanced Chemo‐Immunotherapy Strategy Utilizing Injectable Thermosensitive Hydrogel for The Treatment of Diffuse Peritoneal Metastasis in Advanced Colorectal Cancer},
  journal = {Advanced Science},
  year = {2023},
  doi = {10.1002/advs.202303819}
}
Kostenlos starten →